Synthetic oligonucleotides: the development of antisense therapeutics (Q33657584)

28 July 2017

1 reference

title

Synthetic oligonucleotides: the development of antisense therapeutics (English)

1 reference

28 July 2017

D K Monteith

1

1 reference

28 July 2017

A A Levin

series ordinal

2

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

28 July 2017

published in

Toxicologic Pathology

1 reference

28 July 2017

volume

27

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

8-13

1 reference

Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitors

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Antisense oligonucleotides: is the glass half full or half empty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Identification and characterization of second-generation antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Inhibition of coagulation by a phosphorothioate oligonucleotide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Studies on Poly I:C toxicity in experimental animals*1, *2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Oligonucleotide sequences required for natural killer cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Recent status of the antisense oligonucleotide approaches in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Molecular and cellular characterization of baboon C-Raf as a target for antiproliferative effects of antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

A synthetic single-stranded DNA, poly(dG,dC), induces interferon-alpha/beta and -gamma, augments natural killer activity, and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700103

10.1177/019262339902700103

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference